Enriched with Glutathione & Kojic Acid, it effectively brightens skin, reducing dark spots and pigmentation
It can improve the nutritive status of the animal and lead to improved muscular performance
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Medication Interactions: Certain medications, like proton pump inhibitors and metformin, may interfere with B12 absorption
After an a priori decision to focus on a particular part of the spectrum, metabolites are generally reported as a ratio (one metabolite vs